Sale!

Immunohistochemistry FLI-1 Test

510 د.إ

-11%

The Immunohistochemistry FLI-1 test is a specialized diagnostic procedure utilized to detect the presence of the FLI-1 protein, which is a transcription factor involved in the regulation of gene expression. This test plays a crucial role in the diagnosis and research of certain types of cancers, including Ewing sarcoma and other related soft tissue tumors, where FLI-1 protein expression is typically upregulated.

Performed in state-of-the-art laboratories such as DNA Labs UAE, this test involves the application of specific antibodies against the FLI-1 protein on tissue samples, followed by visualization under a microscope. The presence and intensity of staining help in determining the expression levels of the FLI-1 protein, providing valuable insights for accurate diagnosis and treatment planning.

The cost of the Immunohistochemistry FLI-1 test at DNA Labs UAE is 510 AED. This price reflects the sophisticated nature of the test, including the expertise required to accurately perform and interpret the results. Patients undergoing this test at DNA Labs UAE can expect high-quality services and reliable results, contributing to effective disease management.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

IMMUNOHISTOCHEMISTRY FLI-1 Test

Test Name: IMMUNOHISTOCHEMISTRY FLI-1 Test

Components: FLI-1 protein

Price: 510.0 AED

Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Report Delivery: Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex: 7 days

Method: Immunohistochemistry

Test Type: Cancer

Doctor: Oncologist

Test Department: HISTOLOGY

Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.

Test Details

The FLI-1 test is an immunohistochemistry (IHC) test used to detect the presence of FLI-1 protein in tissues. FLI-1 is a transcription factor that plays a crucial role in the development of blood vessels and hematopoietic cells.

The FLI-1 test is primarily used in the diagnosis of certain types of tumors, such as Ewing’s sarcoma, primitive neuroectodermal tumors, and angiosarcoma. These tumors often show overexpression of FLI-1 protein, which can be detected through IHC.

During the FLI-1 test, a tissue sample (usually obtained through a biopsy) is treated with specific antibodies that bind to FLI-1 protein. These antibodies are usually labeled with a dye or an enzyme, which allows for visualization of the protein under a microscope. If FLI-1 protein is present in the tissue, it will bind to the antibodies and appear as a positive staining pattern.

The FLI-1 test can provide important diagnostic and prognostic information for patients with certain types of tumors. It can help differentiate between different tumor types and guide treatment decisions. However, it is important to note that the FLI-1 test is just one component of a comprehensive diagnostic workup and should be interpreted in conjunction with other clinical and pathological findings.

Test Name IMMUNOHISTOCHEMISTRY FLI-1 Test
Components
Price 510.0 AED
Sample Condition Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days
Method Immunohistochemistry
Test type Cancer
Doctor Oncologist
Test Department: HISTOLOGY
Pre Test Information Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details

The FLI-1 test is an immunohistochemistry (IHC) test used to detect the presence of FLI-1 protein in tissues. FLI-1 is a transcription factor that plays a crucial role in the development of blood vessels and hematopoietic cells.

The FLI-1 test is primarily used in the diagnosis of certain types of tumors, such as Ewing’s sarcoma, primitive neuroectodermal tumors, and angiosarcoma. These tumors often show overexpression of FLI-1 protein, which can be detected through IHC.

During the FLI-1 test, a tissue sample (usually obtained through a biopsy) is treated with specific antibodies that bind to FLI-1 protein. These antibodies are usually labeled with a dye or an enzyme, which allows for visualization of the protein under a microscope. If FLI-1 protein is present in the tissue, it will bind to the antibodies and appear as a positive staining pattern.

The FLI-1 test can provide important diagnostic and prognostic information for patients with certain types of tumors. It can help differentiate between different tumor types and guide treatment decisions. However, it is important to note that the FLI-1 test is just one component of a comprehensive diagnostic workup and should be interpreted in conjunction with other clinical and pathological findings.